Bill of Lading
IGLBMU21362NHCRA
Product category
Residual products of the chemical or allied industries, not elsewhere specified or included; municipal waste; sewage sludge; other wastes specified in note 6 to this chapter
Product description
1669 PACKAGES PACKED IN 38 PALLETS METRONIDAZOLE INJECTION USP 500MG100ML 5MGML NDC NO: 47335-993-01 ANDA NO: 212435 FDA CODE: 62 L C N40
Notify Party Name
Taro Pharmaceuticals Usa Inc
Notify Party Address
1 COMMERCE DRIVE SOUTH BRUNSWICK TOWNSHIP CRANBURY NJ 08512 US
Arrival date
2023-10-03
Bill of lading
IGLBMU21362NHCRA
Master bill of lading
MEDUUI029361
Hs code
382590
Shipment origin
Country of origin
INDIA Port of loading
53313, JAWAHARLAL NEHRUSupplier name
GLAND PHARMA LIMITED
Supplier address
NEAR GANDIMAISAMMA MANDAL MEDCHAL- ALKAIQIRI DISTRICT 700 TELANGANA HYDERABAD 500043 IN Place of receipt
NHAVA SHEVA Shipment destination
Country of arrival
United States of America Port of arrival
4601, NEW YORK/NEWARK AREA, NEWARK, NJ Consignee name
Taro Pharmaceuticals Usa Inc
Consignee address
1 COMMERCE DRIVE SOUTH BRUNSWICK TOWNSHIP CRANBURY NJ 08512 US Notify party address
1 COMMERCE DRIVE SOUTH BRUNSWICK TOWNSHIP CRANBURY NJ 08512 US Carrier details
Vessel Name
America
Vessel code
9285990
Carrier SASC Code
IGLB
Vessel country
Cyprus Voyage
IU335
Container ID
MEDU9851895
Quantity
1669
Weight
7737 KG
TEU
1.5
CIF
N/A
Container size
4000*900*800